Although topical STA-9090 treatment elicited neither skin irritation nor signs of systemic toxicity such as weight loss or death in mice with AD, long-term safety studies of topical Hsp90 inhibitors are still needed. This evidence concerns the gene HSP90AB1 and Alzheimer disease.